3 Evidence-Based Reasons Medicare Negotiation Makes Sense
Drug Prices
3 Evidence-Based Reasons Medicare Negotiation Makes Sense

Landmark Drug Pricing Reforms Moving Forward
Drug Prices
Landmark Drug Pricing Reforms Moving Forward
5 Things to Watch in 2023 in Health Care
Drug Prices
5 Things to Watch in 2023 in Health Care
Look Ahead

5 Big Wins in 2022 for Health Care
Drug Prices
5 Big Wins in 2022 for Health Care
2022 Year in Review

How Medicare Drug Price Negotiations Finally Became Law
Drug Prices
How Medicare Drug Price Negotiations Finally Became Law
Q&A

3 Ways Drug Pricing Reforms in Congress Will Help People
Drug Prices
3 Ways Drug Pricing Reforms in Congress Will Help People

Physician on a Mission: Prescribing Timely FDA Reforms to Ensure Patient Safety
Drug Prices
Physician on a Mission: Prescribing Timely FDA Reforms to Ensure Patient Safety
Q&A

High Brand-Name Net Prices — and List Prices — Support Reforms to Medicare Part D
Drug Prices
High Brand-Name Net Prices — and List Prices — Support Reforms to Medicare Part D

Medicare Negotiation Hearing: 3 Key Takeaways
Drug Prices
Medicare Negotiation Hearing: 3 Key Takeaways

Aduhelm Only Latest Drug to Make Case for Reform
Drug Prices
Aduhelm Only Latest Drug to Make Case for Reform

A New Generation in the Fight for Fair Drug Prices
Drug Prices
A New Generation in the Fight for Fair Drug Prices
Q&A

A New Way to Begin the End of HIV in the U.S.
Drug Prices
A New Way to Begin the End of HIV in the U.S.
Q&A

5 Things to Watch in Health Care in 2022
Drug Prices
5 Things to Watch in Health Care in 2022
Look Ahead

About Us
We strive to maximize opportunity and minimize injustice by investing in systemic solutions that will outlast our funding.
- Criminal Justice
- Evidence-Based Policy
- Contraceptive Choice and Access
- Gun Policy Research
- Policing
- Complex Care
- Drug Prices
- Higher Education